Human polyomavirus 6 DNA in the cerebrospinal fluid of an HIV-positive patient with leukoencephalopathy

Journal of Clinical Virology

Volumn 68, Issue , 2015, Pages 24-27

  Delbue, Serena ^a   Elia, Francesca ^a   Signorini, Lucia ^a   Bella, Ramona ^a   Villani, Sonia ^a   Marchioni, Enrico ^b   Ferrante, Pasquale ^a   Phan, Tung Gia ^c,d   Delwart, Eric ^c,d  

^a UNIVERSITY OF MILAN   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebrospinal fluid; Deep sequencing; Leukoencephalopathy; Polyomaviruses

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN POLYOMAVIRUS 6; JC VIRUS; LEUKOENCEPHALOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID AMPLIFICATION; POLYOMAVIRUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VARICELLA ZOSTER VIRUS; VIRUS ETIOLOGY; VIRUS GENOME; VIRUS LOAD; CLASSIFICATION; COMPLICATION; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; VIROLOGY;

ADULT; CEREBROSPINAL FLUID; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; LEUKOENCEPHALOPATHIES; MALE; MIDDLE AGED; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84930531520     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.04.016     Document Type: Article

References (23)

1. Brooks B.R., Walker D.L. Progressive multifocal leukoencephalopathy. Neurol. Clin. 1984, 2:299-313.
2. Berger J.R. Progressive multifocal leukoencephalopathy and newer biological agents. Drug Saf. 2010, 33:969-983.
3. Dworkin M.S. A review of progressive multifocal leukoencephalopathy in persons with and without AIDS. Curr. Clin. Top. Infect. Dis. 2002, 22:181-195.
4. Lima M.A., Bernal-Cano F., Clifford D.B., Gandhi R.T., Koralnik I.J. Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J. Neurol. Neurosurg. Psychiatry 2010, 81:1288-1291.
5. Langford T.D., Letendre S.L., Larrea G.J., Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol. 2003, 13:e195-e210.
6. Guerini F.R., Delbue S., Zanzottera M., Agliardi C., Saresella M., Mancuso R., Maserati R., Marchioni E., Gori A., Ferrante P. Analysis of CCR5CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathy. Biomed. Pharmacother. 2008, 62:26-30.
7. Delbue S., Sotgiu G., Fumagalli D., Valli M., Borghi E., Mancuso R., Marchioni E., Maserati R., Ferrante P. A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine. J. Neurovirol. 2005, 11:51-57.
8. Delbue S., Elia F., Carloni C., Tavazzi E., Marchioni E., Carluccio S., Signorini L., Novati S., Maserati R., Ferrante P. JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy. J. Cell Physiol. 2012, 227:3511-3517.
9. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature 1989, 339:237-238.
10. Siebrasse E.A., Bauer I., Holtz L.R., Le B.-M., Lassa-Claxton S., et al. Human polyomaviruses in children undergoing transplantation, United States, 2008-2010. Emerging Infect. Dis. 2012, 18:1676-1679.
11. Schowalter R.M., Pastrana D.V., Pumphrey K.A., Moyer A.L., Buck C.B. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010, 7:509-515.
12. Casado J.L., Corral I., García J., Martinez-San Millán J., Navas E., Moreno A., Moreno S. Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33:179-187.
13. Tretiakova A., Krynska B., Gordon J., Khalili K. Human neurotropic JC virus early protein deregulates glial cell cycle pathway and impairs cell differentiation. J. Neurosci. Res. 1999, 55:588-599.
14. Kaniowska D., Kaminski R., Amini S., Radhakrishnan S., Rappaport J., Johnson E., Khalili K., Del Valle L., Darbinyan A. Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells. J. Virol. 2006, 80:9288-9299.
15. Nicol J.T., Robinot R., Carpentier A., Carandina G., Mazzoni E., Tognon M., Touzé A., Coursaget P. Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9: and trichodysplasia spinulosa-associatedpolyomavirus. Clin. Vaccine Immunol. 2013, 20:363-368.
16. van der Meijden E., Bialasiewicz S., Rockett R.J., Tozer S.J., Sloots T.P., Feltkamp M.C. Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin. PLoS ONE 2013, 8:e81078.
17. Wieland U., Silling S., Hellmich M., Potthoff A., Pfister H., Kreuter A. Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa-associated Polyomavirus in HIV-infected men. J. Gen. Virol. 2014, 95:928-932.
18. Schrama D., Groesser L., Ugurel S., Hafner C., Pastrana D.V., Buck C.B., Cerroni L., Theiler A., Becker J.C. Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations. JAMA Dermatol. 2014, 150:1180-1186.
19. Duncavage E.J., Pfeifer J.D. Human polyomaviruses 6 and 7 are not detectable in Merkel cell polyomavirus-negative Merkel cell carcinoma. J. Cutan. Pathol. 2011, 38:790-796.
20. Rockett R.J., Sloots T.P., Bowes S., O'Neill N., Ye S., Robson J., Whiley D.M., Lambert S.B., Wang D., Nissen M.D., Bialasiewicz S. Detection of novel polyomaviruses, TSPyV, HPyV6, HPyV7, HPyV9 and MWPyV in feces, urine, blood, respiratory swabs and cerebrospinal fluid. PLoS ONE 2013, 8:e62764.
21. McDonald C.P., Roy A., Mahajan P., Smith R., Charlett A., Barbara J.A. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang. 2004, 86:178-182.
22. Bruneau C., Perez P., Chassaigne M., Allouch P., Audurier A., Gulian C., Janus G., Boulard G., De Micco P., Salmi L.R., Noel L. Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations. Transfusion 2001, 41:74-81.
23. Greninger A.L., Naccache S.N., Messacar K., Clayton A., Yu G., Somasekar S., Federman S., Stryke D., Anderson C., Yagi S., Messenger S., Wadford D., Xia D., Watt J.P., Van Haren K., Dominguez S.R., Glaser C., Aldrovandi G., Chiu C.Y. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study. Lancet. Infect. Dis. 2015, (Suppl. 1473-3099):70093-70099.